Found: 44
Select item for more details and to access through your institution.
Cancer Antigen 125 Associated With Multiple Benign and Malignant Pathologies.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2003, v. 10, n. 2, p. 150, doi. 10.1245/ASO.2003.05.015
- By:
- Publication type:
- Article
Future care for long‑term cancer survivors: towards a new model.
- Published in:
- Clinical & Translational Oncology, 2022, v. 24, n. 2, p. 350, doi. 10.1007/s12094-021-02696-5
- By:
- Publication type:
- Article
Overall survival for early and locally advanced non-small-cell lung cancer from one institution: 2000–2017.
- Published in:
- Clinical & Translational Oncology, 2021, v. 23, n. 7, p. 1325, doi. 10.1007/s12094-020-02521-5
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of small-cell lung cancer (SCLC) (2019).
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 2, p. 245, doi. 10.1007/s12094-020-02295-w
- By:
- Publication type:
- Article
Multidisciplinary consensus statement on the clinical management of patients with stage III non-small cell lung cancer.
- Published in:
- Clinical & Translational Oncology, 2020, v. 22, n. 1, p. 21, doi. 10.1007/s12094-019-02134-7
- By:
- Publication type:
- Article
Applying Data Science methods and tools to unveil healthcare use of lung cancer patients in a teaching hospital in Spain.
- Published in:
- Clinical & Translational Oncology, 2019, v. 21, n. 11, p. 1472, doi. 10.1007/s12094-019-02074-2
- By:
- Publication type:
- Article
Consensus on the use of immune-related response criteria to evaluate the efficacy of immunotherapy in non-small cell lung cancer.
- Published in:
- Clinical & Translational Oncology, 2019, v. 21, n. 11, p. 1464, doi. 10.1007/s12094-019-02072-4
- By:
- Publication type:
- Article
A combination of hydroxytyrosol, omega-3 fatty acids and curcumin improves pain and inflammation among early stage breast cancer patients receiving adjuvant hormonal therapy: results of a pilot study.
- Published in:
- Clinical & Translational Oncology, 2019, v. 21, n. 4, p. 489, doi. 10.1007/s12094-018-1950-0
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018).
- Published in:
- Clinical & Translational Oncology, 2019, v. 21, n. 1, p. 3, doi. 10.1007/s12094-018-1978-1
- By:
- Publication type:
- Article
Efficacy of tyrosine kinase inhibitors in EGFR-mutant lung cancer women in a real-world setting: the WORLD07 database.
- Published in:
- Clinical & Translational Oncology, 2017, v. 19, n. 12, p. 1537, doi. 10.1007/s12094-017-1700-8
- By:
- Publication type:
- Article
Spotlight on the relevance of mtDNA in cancer.
- Published in:
- Clinical & Translational Oncology, 2017, v. 19, n. 4, p. 409, doi. 10.1007/s12094-016-1561-6
- By:
- Publication type:
- Article
Lung cancer and other second neoplasms after treatment of Hodgkin lymphoma.
- Published in:
- Clinical & Translational Oncology, 2016, v. 18, n. 1, p. 99, doi. 10.1007/s12094-015-1342-7
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of Hodgkin's lymphoma.
- Published in:
- Clinical & Translational Oncology, 2015, v. 17, n. 12, p. 1005, doi. 10.1007/s12094-015-1429-1
- By:
- Publication type:
- Article
SEOM clinical guidelines for the treatment of follicular non-Hodgkin's lymphoma.
- Published in:
- Clinical & Translational Oncology, 2015, v. 17, n. 12, p. 1014, doi. 10.1007/s12094-015-1437-1
- By:
- Publication type:
- Article
Aldehyde dehydrogenases in early stage lung cancer: nuclear expression.
- Published in:
- Clinical & Translational Oncology, 2014, v. 16, n. 10, p. 931, doi. 10.1007/s12094-014-1173-y
- By:
- Publication type:
- Article
Erratum to: Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary.
- Published in:
- 2013
- By:
- Publication type:
- Correction Notice
Cisplatin plus oral vinorelbine as first-line treatment for advanced non-small-cell lung cancer: a prospective study confirming that the day-8 hemogram is unnecessary.
- Published in:
- Clinical & Translational Oncology, 2013, v. 15, n. 8, p. 659, doi. 10.1007/s12094-012-0989-6
- By:
- Publication type:
- Article
Prevalence and management of anaemia in patients with non-myeloid cancer undergoing systemic therapy: a Spanish survey.
- Published in:
- Clinical & Translational Oncology, 2013, v. 15, n. 6, p. 477, doi. 10.1007/s12094-012-0953-5
- By:
- Publication type:
- Article
Surveillance of resected non-small cell lung cancer.
- Published in:
- Clinical & Translational Oncology, 2012, v. 14, n. 10, p. 721, doi. 10.1007/s12094-012-0841-z
- By:
- Publication type:
- Article
BRCA1 Mutations in Patients with Familial Risk of Breast Cancer.
- Published in:
- Acta Oncologica, 1998, v. 37, n. 3, p. 299, doi. 10.1080/028418698429612
- By:
- Publication type:
- Article
Pain relief and quality of life of 686 cancer patients.
- Published in:
- 2013
- By:
- Publication type:
- Abstract
Cerebral infarction after cisplatin-based chemotherapy.
- Published in:
- 1994
- By:
- Publication type:
- Case Study
Intracranial tuberculoma: paradoxical expansion during medical treatment.
- Published in:
- 1992
- By:
- Publication type:
- Case Study
Lung cancer risk associated with occupations in women: a pooling study.
- Published in:
- Occupational Medicine, 2024, v. 74, n. 5, p. 348, doi. 10.1093/occmed/kqae050
- By:
- Publication type:
- Article
Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 70, n. 6, p. 883, doi. 10.1007/s00280-012-1985-9
- By:
- Publication type:
- Article
ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA: UPDATED ANALYSIS OF THE ROSEWOOD STUDY.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 119, doi. 10.1002/hon.3163_81
- By:
- Publication type:
- Article
Final safety and efficacy results of copanlisib monotherapy in patients with relapsed or refractory iNHL: 6‐year follow‐up of CHRONOS‐1.
- Published in:
- Hematological Oncology, 2023, v. 41, p. 560, doi. 10.1002/hon.3164_420
- By:
- Publication type:
- Article
NIVOLUMAB FOR RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL) AFTER AUTOLOGOUS TRANSPLANTATION: 5‐YEAR OVERALL SURVIVAL FROM THE PHASE 2 CHECKMATE 205 STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.74_2879
- By:
- Publication type:
- Article
NIVOLUMAB FOR RELAPSED OR REFRACTORY (R/R) CLASSICAL HODGKIN LYMPHOMA (CHL) AFTER AUTOLOGOUS TRANSPLANTATION: 5‐YEAR OVERALL SURVIVAL FROM THE PHASE 2 CHECKMATE 205 STUDY.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.70_2880
- By:
- Publication type:
- Article
LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. PRELIMINARY RESULTS OF THE R2‐GDP‐GOTEL TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 258, doi. 10.1002/hon.67_2630
- By:
- Publication type:
- Article
SAFETY ANALYSIS OF PATIENTS WITH A MEDICAL HISTORY OF RESPIRATORY DISORDERS TREATED WITH COPANLISIB FROM THE CHRONOS‐1 STUDY IN RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 389, doi. 10.1002/hon.58_2631
- By:
- Publication type:
- Article
EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 387, doi. 10.1002/hon.57_2631
- By:
- Publication type:
- Article
DIFFUSE LARGE B‐CELL LYMPHOMA SURVIVAL PROGNOSTICATION, A COMPARATIVE ANALYSIS OF CELL OF ORIGIN VS. MYC/BCL2 EXPRESSION.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 353, doi. 10.1002/hon.15_2631
- By:
- Publication type:
- Article
NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED‐STAGE CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 205 COHORT D 2‐YEAR FOLLOW‐UP.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 146, doi. 10.1002/hon.104_2629
- By:
- Publication type:
- Article
LENALIDOMIDE PLUS R‐GDP (R2‐GDP) IN RELAPSED/REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA. PRELIMINARY RESULTS OF THE R2‐GDP‐GOTEL TRIAL.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 258, doi. 10.1002/hon.67_2630
- By:
- Publication type:
- Article
SAFETY ANALYSIS OF PATIENTS WITH A MEDICAL HISTORY OF RESPIRATORY DISORDERS TREATED WITH COPANLISIB FROM THE CHRONOS‐1 STUDY IN RELAPSED OR REFRACTORY INDOLENT B‐CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 389, doi. 10.1002/hon.58_2631
- By:
- Publication type:
- Article
EFFICACY AND SAFETY IN HIGH‐RISK RELAPSED OR REFRACTORY INDOLENT FOLLICULAR LYMPHOMA PATIENTS TREATED WITH COPANLISIB.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 387, doi. 10.1002/hon.57_2631
- By:
- Publication type:
- Article
DIFFUSE LARGE B‐CELL LYMPHOMA SURVIVAL PROGNOSTICATION, A COMPARATIVE ANALYSIS OF CELL OF ORIGIN VS. MYC/BCL2 EXPRESSION.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 353, doi. 10.1002/hon.15_2631
- By:
- Publication type:
- Article
NIVOLUMAB PLUS DOXORUBICIN, VINBLASTINE AND DACARBAZINE FOR NEWLY DIAGNOSED ADVANCED‐STAGE CLASSICAL HODGKIN LYMPHOMA: CHECKMATE 205 COHORT D 2‐YEAR FOLLOW‐UP.
- Published in:
- Hematological Oncology, 2019, v. 37, p. 146, doi. 10.1002/hon.104_2629
- By:
- Publication type:
- Article
APPLICATION OF CELL-OF-ORIGIN SUBTYPES DETERMINED BY DIGITAL GENE EXPRESSION IN HIV-RELATED DIFFUSE LARGE B-CELL LYMPHOMAS.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 156, doi. 10.1002/hon.2438_11
- By:
- Publication type:
- Article
Mutational status of K- ras and TP53 genes in primary sarcomas of the heart.
- Published in:
- British Journal of Cancer, 2000, v. 82, n. 6, p. 1183, doi. 10.1054/bjoc.1999.1060
- By:
- Publication type:
- Article
Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations.
- Published in:
- British Journal of Cancer, 1999, v. 81, n. 3, p. 503, doi. 10.1038/sj.bjc.6690722
- By:
- Publication type:
- Article
Aberrant DNA methylation of the p16<sup>INK4a</sup> gene in plasma DNA of breast cancer patients.
- Published in:
- British Journal of Cancer, 1999, v. 80, n. 8, p. 1262, doi. 10.1038/sj.bjc.6690495
- By:
- Publication type:
- Article
Central nervous system involvement in Hodgkin's lymphoma.
- Published in:
- Medical Oncology, 2011, v. 28, p. 505, doi. 10.1007/s12032-010-9692-z
- By:
- Publication type:
- Article